Israël - hébreu - Ministry of Health

lapidot medical import and marketing ltd - glucose monohydrate; sodium chloride - תמיסה לאינפוזיה - glucose monohydrate 55 mg / 1 ml; sodium chloride 4.5 mg / 1 ml - electrolytes with carbohydrates

Israël - hébreu - Ministry of Health

lapidot medical import and marketing ltd - glucose monohydrate; sodium chloride - תמיסה לאינפוזיה - glucose monohydrate 55 mg / 1 ml; sodium chloride 4.5 mg / 1 ml - electrolytes with carbohydrates

Israël - hébreu - Ministry of Health

lapidot medical import and marketing ltd - calcium chloride dihydrate; magnesium chloride hexahydrate; potassium chloride; sodium acetate trihydrate; sodium chloride; succinylated gelatin - תמיסה לאינפוזיה - succinylated gelatin 40 mg/ml l; magnesium chloride hexahydrate 0.20 mg/ml l; calcium chloride dihydrate 0.15 mg/ml l; potassium chloride 0.30 mg/ml l; sodium acetate trihydrate 3.27 mg/ml l; sodium chloride 5.55 mg/ml l - gelatin agents

Israël - hébreu - Ministry of Health

lapidot medical import and marketing ltd - amikacin as sulfate - תמיסה לאינפוזיה - amikacin as sulfate 10 mg / 1 ml - amikacin

Israël - hébreu - Ministry of Health

lapidot medical import and marketing ltd - amikacin as sulfate - תמיסה לאינפוזיה - amikacin as sulfate 5 mg / 1 ml - amikacin

Israël - hébreu - Ministry of Health

lapidot medical import and marketing ltd - omega-3; soya bean oil, refined; triglycerides, medium-chain - תחליב לאינפוזיה - omega-3 20 mg / 1 ml; soya bean oil, refined 80 mg / 1 ml; triglycerides, medium-chain 100 mg / 1 ml - fat emulsions

Israël - hébreu - Ministry of Health

lapidot medical import and marketing ltd - heparin sodium - תמיסה להזרקה\אינפוזיה - heparin sodium 5000 iu - heparin

Israël - hébreu - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

Israël - hébreu - Ministry of Health

מדיסון פארמה בע"מ - מומחה - מיקרו קטטר

Israël - hébreu - Ministry of Health

tzamal medical ltd - רופא - מיכשור, ציוד ואביזרים לכירורגיה